Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
754.430.39%
QQQ
704.710.02%
BTC/USD
75693.500.1446%
DIA
516.550.9%
GLD
391.360.71%
TLT
81.060.43%

LifeStance Health Group Inc

LFSTNASDAQ
Trade with Public
Trade with Public
$12.96
-0.11-0.8%
Last update: Sep 16, 2:58 PM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

LifeStance Health Gr Analyst Price Targets

Wall Street analyst price targets and consensus rating for LifeStance Health Gr (LFST).

Price Target Range — 11 Quarters

Analyst Consensus — 10 Analysts

8Buy
2Hold
Consensus RatingBuy# Analysts10Avg. Consensus PT$11Upside to Avg. PT-14.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 10, 2026BarclaysPeter WarendorfPT RaiseOverweight$13→$15
Sep 9, 2026Canaccord GenuityRichard ClosePT RaiseBuy$13→$15
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15

Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.
Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15

Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $13 to $15.
Benzinga Newsdesk

PRO
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $18

BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $16 to $18.
Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13

JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $9 to $13.
Benzinga Newsdesk

PRO
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $16

BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.
Benzinga Newsdesk

PRO
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $15

BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $12 to $15.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved